Simultaneous determination of atenolol and chlorthalidone by LC-MS-MS in human plasma

Chromatographia

Volumn 68, Issue 9-10, 2008, Pages 721-729

  Khuroo, Arshad ^a   Mishra, Sanjeev ^a   Singh, Onkar ^a   Saxena, Saurabh ^a   Monif, Tausif ^a  

^a HSIDC   (India)

Author keywords

Atenolol and chlorthalidone in human plasma; Column liquid chromatography mass spectrometry

Indexed keywords

ATENOLOL; CHLORTALIDONE; HYDROCHLOROTHIAZIDE; METOPROLOL;

ARTICLE; CONTROLLED STUDY; DRUG ANALYSIS; DRUG DETERMINATION; DRUG STABILITY; DRUG STRUCTURE; HUMAN; LIQUID CHROMATOGRAPHY; PLASMA; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 55349122154     PISSN: 00095893     EISSN: 16121112     Source Type: Journal    
DOI: 10.1365/s10337-008-0755-7     Document Type: Article

References (21)

1. MJ Klag PK Whelton BL Randall JD Neaton FL Brancati CE Ford 1996 N Engl J Med 334 13 18 10.1056/NEJM199601043340103
2. J Coresh GL Wei G McQuillan FL Brancati AS Levey C Jones 2001 Arch Intern Med 161 9 1207 1216 10.1001/archinte.161.9.1207
3. PM Kearney M Whelton K Reynolds P Muntner PK Whelton J He 2005 Lancet 365 9455 217 223
4. S Lewington R Clarke N Qizilbash R Peto R Collins 2002 Lancet 360 9349 1903 1913 10.1016/S0140-6736(02)11911-8
5. RD Johnson RJ Lewis 2006 Forensic Sci Int 156 2-3 106 117 10.1016/j.forsciint.2005.01.001
6. Medical Research Council Working Party on Mild to Moderate Hypertension 1992 Medical research trial on treatment of hypertension in older adults: principal results BMJ 304 405 412
7. DS Siscovick TE Raghunathan BM Psaty TD Koepsell KG Wicklund X Lin 1994 N Engl J Med 330 1852 1857 10.1056/NEJM199406303302603
8. R Collins R Peto S MacMahon P Hebert NH Fiebach KA Eberlein 1990 Lancet 335 827 838 10.1016/0140-6736(90)90944-Z
9. DA Sica 1994 Drugs 48 16 24 10.2165/00003495-199448010-00003
10. JM Neutel HR Black MA Weber 1996 Am J Med 101 61 70 10.1016/S0002- 9343(96)00269-0
11. H Kataoka HL Lord J Pawliszyn 1999 Anal Chem 71 4237 4244 10.1021/ac990356x
12. ME Abdel-Hamid 2000 Farmaco 55 2 136 145 10.1016/S0014-827X(00)00006-9
13. R Johnson R Lewis 2006 Forensic Sci Int 156 2 106 117 10.1016/j.forsciint.2005.01.001
14. M Ervik K Gustavii 1974 Anal Chem 46 39 42 10.1021/ac60337a046
15. PH Degen A Schweizer 1977 J Chromatogr A 142 549 557 10.1016/S0021- 9673(01)92067-9
16. MJ Rosenberg KK Lam TE Dorsey 1986 J Chromatogr A 375 438
17. R MacGregor PR Farina M Hagopian N Hay HJ Esber J Jkeirns 1984 Ther Drug Monit 6 83 10.1097/00007691-198403000-00014
18. D Dadgar MT Kelly 1988 Analyst Lond 113 113 10.1039/an9881300113
19. DC Muirhead RB Christie 1987 J Chromatgr 416 420 10.1016/0378-4347(87) 80530-3
20. Guidance for industry: bioanalytical method validation, US department of health and human services, food and drug administration centre for drug evaluation and research (CDER), centre for veterinary medicine (CBM), May 2001
21. FDA guidance for industry: bioavailability studies for orally administered drug-products- general considerations, US department of health and human services, food and drug administration centre for drug evaluation and research (CDER) 2000